Report Detail
Global Acinetobacter Infections Treatment Market Growth 2019-2024
- RnM2988975 |
- 20 February, 2019 |
- Global |
- 167 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
In the last several years, global market of Acinetobacter Infections Treatment developed rapidly, with an average growth rate of 2.96%. In 2016, United States Market Size of Acinetobacter Infections Treatment is nearly 22 M USD. For developing product, there are 1 in Phase III, 1 in Phase Ⅱ, 4 in Phase 1 and 8 in Preclinical. The total investment for Acinetobacter Infections Treatmen Drugs developing is around 90 M USD.
The global average Cost of Acinetobacter Infections Treatment is in the decreasing trend, from 2901 USD/Case in 2012 to2870 USD/Case in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Acinetobacter Infections Treatment includes Sulbactam, Carbapenems , Aminoglycosides, Polymyxins, Tigecycline and Others Treatment, and the proportion of Aminoglycosides in 2016 is about 18%, and the proportion is in decreasing trend from 2012 to 2016.
According to this study, over the next five years the Acinetobacter Infections Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Acinetobacter Infections Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Acinetobacter Infections Treatment market by product type, application, key manufacturers and key regions and countries.
This study considers the Acinetobacter Infections Treatment value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Sulbactam
Carbapenems
Aminoglycosides
Polymyxins
Tetracyclines
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Application I
Application II
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Acinetobacter Infections Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Acinetobacter Infections Treatment market by identifying its various subsegments.
Focuses on the key global Acinetobacter Infections Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Acinetobacter Infections Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Acinetobacter Infections Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Acinetobacter Infections Treatment Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Acinetobacter Infections Treatment Consumption 2014-2024
- 2.1.2 Acinetobacter Infections Treatment Consumption CAGR by Region
- 2.2 Acinetobacter Infections Treatment Segment by Type
- 2.2.1 Sulbactam
- 2.2.2 Carbapenems
- 2.2.3 Aminoglycosides
- 2.2.4 Polymyxins
- 2.2.5 Tetracyclines
- 2.2.6 Others
- 2.3 Acinetobacter Infections Treatment Consumption by Type
- 2.3.1 Global Acinetobacter Infections Treatment Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Acinetobacter Infections Treatment Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Acinetobacter Infections Treatment Sale Price by Type (2014-2019)
- 2.4 Acinetobacter Infections Treatment Segment by Application
- 2.4.1 Application I
- 2.4.2 Application II
- 2.5 Acinetobacter Infections Treatment Consumption by Application
- 2.5.1 Global Acinetobacter Infections Treatment Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Acinetobacter Infections Treatment Value and Market Share by Application (2014-2019)
- 2.5.3 Global Acinetobacter Infections Treatment Sale Price by Application (2014-2019)
3 Global Acinetobacter Infections Treatment by Players
- 3.1 Global Acinetobacter Infections Treatment Sales Market Share by Players
- 3.1.1 Global Acinetobacter Infections Treatment Sales by Players (2017-2019)
- 3.1.2 Global Acinetobacter Infections Treatment Sales Market Share by Players (2017-2019)
- 3.2 Global Acinetobacter Infections Treatment Revenue Market Share by Players
- 3.2.1 Global Acinetobacter Infections Treatment Revenue by Players (2017-2019)
- 3.2.2 Global Acinetobacter Infections Treatment Revenue Market Share by Players (2017-2019)
- 3.3 Global Acinetobacter Infections Treatment Sale Price by Players
- 3.4 Global Acinetobacter Infections Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Acinetobacter Infections Treatment Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Acinetobacter Infections Treatment Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Acinetobacter Infections Treatment by Regions
- 4.1 Acinetobacter Infections Treatment by Regions
- 4.1.1 Global Acinetobacter Infections Treatment Consumption by Regions
- 4.1.2 Global Acinetobacter Infections Treatment Value by Regions
- 4.2 Americas Acinetobacter Infections Treatment Consumption Growth
- 4.3 APAC Acinetobacter Infections Treatment Consumption Growth
- 4.4 Europe Acinetobacter Infections Treatment Consumption Growth
- 4.5 Middle East & Africa Acinetobacter Infections Treatment Consumption Growth
5 Americas
- 5.1 Americas Acinetobacter Infections Treatment Consumption by Countries
- 5.1.1 Americas Acinetobacter Infections Treatment Consumption by Countries (2014-2019)
- 5.1.2 Americas Acinetobacter Infections Treatment Value by Countries (2014-2019)
- 5.2 Americas Acinetobacter Infections Treatment Consumption by Type
- 5.3 Americas Acinetobacter Infections Treatment Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Acinetobacter Infections Treatment Consumption by Countries
- 6.1.1 APAC Acinetobacter Infections Treatment Consumption by Countries (2014-2019)
- 6.1.2 APAC Acinetobacter Infections Treatment Value by Countries (2014-2019)
- 6.2 APAC Acinetobacter Infections Treatment Consumption by Type
- 6.3 APAC Acinetobacter Infections Treatment Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Acinetobacter Infections Treatment by Countries
- 7.1.1 Europe Acinetobacter Infections Treatment Consumption by Countries (2014-2019)
- 7.1.2 Europe Acinetobacter Infections Treatment Value by Countries (2014-2019)
- 7.2 Europe Acinetobacter Infections Treatment Consumption by Type
- 7.3 Europe Acinetobacter Infections Treatment Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Acinetobacter Infections Treatment by Countries
- 8.1.1 Middle East & Africa Acinetobacter Infections Treatment Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Acinetobacter Infections Treatment Value by Countries (2014-2019)
- 8.2 Middle East & Africa Acinetobacter Infections Treatment Consumption by Type
- 8.3 Middle East & Africa Acinetobacter Infections Treatment Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Acinetobacter Infections Treatment Distributors
- 10.3 Acinetobacter Infections Treatment Customer
11 Global Acinetobacter Infections Treatment Market Forecast
- 11.1 Global Acinetobacter Infections Treatment Consumption Forecast (2019-2024)
- 11.2 Global Acinetobacter Infections Treatment Forecast by Regions
- 11.2.1 Global Acinetobacter Infections Treatment Forecast by Regions (2019-2024)
- 11.2.2 Global Acinetobacter Infections Treatment Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Acinetobacter Infections Treatment Forecast by Type
- 11.8 Global Acinetobacter Infections Treatment Forecast by Application
12 Key Players Analysis
- 12.1 Entasis Therapeutics
- 12.1.1 Company Details
- 12.1.2 Acinetobacter Infections Treatment Product Offered
- 12.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Entasis Therapeutics News
- 12.2 Roche
- 12.2.1 Company Details
- 12.2.2 Acinetobacter Infections Treatment Product Offered
- 12.2.3 Roche Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Roche News
- 12.3 Adenium Biotech
- 12.3.1 Company Details
- 12.3.2 Acinetobacter Infections Treatment Product Offered
- 12.3.3 Adenium Biotech Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Adenium Biotech News
- 12.4 Vaxdyn
- 12.4.1 Company Details
- 12.4.2 Acinetobacter Infections Treatment Product Offered
- 12.4.3 Vaxdyn Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Vaxdyn News
- 12.5 Hsiri Therapeutics
- 12.5.1 Company Details
- 12.5.2 Acinetobacter Infections Treatment Product Offered
- 12.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Hsiri Therapeutics News
- 12.6 Aridis Pharmaceuticals
- 12.6.1 Company Details
- 12.6.2 Acinetobacter Infections Treatment Product Offered
- 12.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Aridis Pharmaceuticals News
- 12.7 LegoChem Biosciences
- 12.7.1 Company Details
- 12.7.2 Acinetobacter Infections Treatment Product Offered
- 12.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 LegoChem Biosciences News
- 12.8 Atterx Biotherapeutics
- 12.8.1 Company Details
- 12.8.2 Acinetobacter Infections Treatment Product Offered
- 12.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Atterx Biotherapeutics News
- 12.9 Achaogen
- 12.9.1 Company Details
- 12.9.2 Acinetobacter Infections Treatment Product Offered
- 12.9.3 Achaogen Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Achaogen News
- 12.10 Peptilogics
- 12.10.1 Company Details
- 12.10.2 Acinetobacter Infections Treatment Product Offered
- 12.10.3 Peptilogics Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Peptilogics News
- 12.11 Sealife PHARMA
- 12.12 Shionogi
- 12.13 Techulon
- 12.14 Tetraphase Pharmaceuticals
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Acinetobacter Infections Treatment . Industry analysis & Market Report on Acinetobacter Infections Treatment is a syndicated market report, published as Global Acinetobacter Infections Treatment Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Acinetobacter Infections Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
